Machina Capital S.A.S. Boosts Holdings in Corteva, Inc. $CTVA

Machina Capital S.A.S. grew its position in Corteva, Inc. (NYSE:CTVAFree Report) by 367.0% during the 3rd quarter, Holdings Channel reports. The fund owned 75,483 shares of the company’s stock after buying an additional 59,319 shares during the quarter. Corteva comprises about 0.9% of Machina Capital S.A.S.’s holdings, making the stock its 18th biggest position. Machina Capital S.A.S.’s holdings in Corteva were worth $5,105,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently modified their holdings of the business. J.W. Cole Advisors Inc. raised its position in Corteva by 3.6% in the third quarter. J.W. Cole Advisors Inc. now owns 24,356 shares of the company’s stock worth $1,647,000 after acquiring an additional 840 shares in the last quarter. Envestnet Asset Management Inc. increased its holdings in shares of Corteva by 5.9% in the 3rd quarter. Envestnet Asset Management Inc. now owns 2,138,576 shares of the company’s stock valued at $144,640,000 after purchasing an additional 119,759 shares in the last quarter. Ashton Thomas Private Wealth LLC increased its holdings in Corteva by 40.3% in the third quarter. Ashton Thomas Private Wealth LLC now owns 8,618 shares of the company’s stock valued at $583,000 after buying an additional 2,476 shares in the last quarter. Premier Path Wealth Partners LLC boosted its stake in shares of Corteva by 4.3% during the 3rd quarter. Premier Path Wealth Partners LLC now owns 10,947 shares of the company’s stock worth $740,000 after acquiring an additional 456 shares in the last quarter. Finally, Compass Financial Services Inc acquired a new stake in shares of Corteva in the 3rd quarter worth approximately $34,000. 81.54% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

CTVA has been the topic of a number of research analyst reports. Oppenheimer boosted their target price on Corteva from $76.00 to $78.00 and gave the stock an “outperform” rating in a research report on Tuesday, January 27th. Wall Street Zen upgraded shares of Corteva from a “hold” rating to a “buy” rating in a research report on Saturday, January 17th. Zacks Research raised shares of Corteva from a “hold” rating to a “strong-buy” rating in a research note on Thursday, January 22nd. Citigroup upped their target price on Corteva from $70.00 to $74.00 and gave the company a “neutral” rating in a research note on Wednesday, January 21st. Finally, Wolfe Research boosted their price target on Corteva from $80.00 to $81.00 and gave the stock an “outperform” rating in a report on Friday, January 16th. Two investment analysts have rated the stock with a Strong Buy rating, fourteen have issued a Buy rating and five have given a Hold rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $79.58.

Read Our Latest Stock Analysis on Corteva

Corteva Stock Up 2.3%

Shares of NYSE CTVA opened at $74.88 on Wednesday. The firm has a market cap of $50.60 billion, a P/E ratio of 32.00, a price-to-earnings-growth ratio of 1.86 and a beta of 0.75. The company has a debt-to-equity ratio of 0.07, a quick ratio of 1.07 and a current ratio of 1.58. Corteva, Inc. has a 1 year low of $53.40 and a 1 year high of $77.41. The firm’s 50 day moving average price is $68.44 and its 200 day moving average price is $68.35.

Corteva (NYSE:CTVAGet Free Report) last issued its quarterly earnings results on Tuesday, February 3rd. The company reported $0.22 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.22. The company had revenue of $3.91 billion for the quarter, compared to analyst estimates of $4.23 billion. Corteva had a return on equity of 9.37% and a net margin of 9.19%.The business’s revenue for the quarter was down 1.7% compared to the same quarter last year. During the same quarter in the prior year, the company posted $0.32 EPS. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. As a group, sell-side analysts anticipate that Corteva, Inc. will post 2.96 earnings per share for the current year.

Corteva Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Monday, March 16th. Stockholders of record on Monday, March 2nd will be paid a dividend of $0.18 per share. The ex-dividend date of this dividend is Monday, March 2nd. This represents a $0.72 dividend on an annualized basis and a dividend yield of 1.0%. Corteva’s dividend payout ratio is currently 30.77%.

Corteva Company Profile

(Free Report)

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.

Featured Stories

Want to see what other hedge funds are holding CTVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Corteva, Inc. (NYSE:CTVAFree Report).

Institutional Ownership by Quarter for Corteva (NYSE:CTVA)

Receive News & Ratings for Corteva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corteva and related companies with MarketBeat.com's FREE daily email newsletter.